rosiglitazone has been researched along with glycerol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chisholm, DJ; Jenkins, AB; Kennedy, CJ; Kraegen, EW; Laybutt, DR; Oakes, ND | 1 |
| Franciosa, MD; Greenberg, AS; Lien, P; Souza, SC; Yamamoto, MT | 1 |
| Befroy, D; Cline, GW; Dufour, S; Enocksson, S; Hundal, RS; Inzucchi, SE; Lebon, V; Mayerson, AB; Petersen, KF; Shulman, GI | 1 |
| Anderson, LA; Barnett, AH; Eggo, MC; Green, A; Harte, AL; Holder, JC; Kumar, S; McTernan, PG; Smith, SA | 1 |
| Arner, P; Dicker, A; Hauner, H; Lönnqvist, F; Näslund, E; Rydén, M; van Harmelen, V | 1 |
| Antoine, B; Beale, EG; Chauvet, G; Forest, C; Quette, J; Tordjman, J | 1 |
| Debard, C; Frayn, KN; Humphreys, SM; Karpe, F; Langin, D; Tan, GD; Tiraby, C; Vidal, H | 1 |
| Cleasby, ME; Cooney, GJ; Dzamko, N; Furler, SM; Hegarty, BD; Kraegen, EW; Ye, JM | 1 |
| Ahn, IS; Do, MS; Hong, SE; Jung, HS; Rayner, DV | 1 |
| Antoine, B; Chapron, C; Chauvet, G; Forest, C; Leroyer, SN; Quette, J; Tordjman, J | 1 |
| Benelli, C; Blouin, JM; Bortoli, S; Cadoudal, T; Collinet, M; Distel, E; Durant, S; Forest, C; Fouque, F | 1 |
| Andres, J; Biedasek, K; Bobbert, T; Clemenz, M; Kintscher, U; Mai, K; Meinus, S; Möhlig, M; Pfeiffer, AF; Reinecke, F; Sabath, M; Spranger, J; Spuler, S; Weicht, J; Weickert, MO | 1 |
| Balasubramanyam, A; D'Amico, S; Jahoor, F; Patel, SG; Rehman, K; Sekhar, RV; Shi, J; Visnegarwala, F | 1 |
| Magkos, F; Mantzoros, CS | 1 |
1 trial(s) available for rosiglitazone and glycerol
| Article | Year |
|---|---|
A "futile cycle" induced by thiazolidinediones in human adipose tissue?
Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; Carrier Proteins; Cells, Cultured; Diabetes Mellitus, Type 2; Enzyme Activation; Fasting; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids, Nonesterified; Glycerol; Glycerol Kinase; Humans; Hypoglycemic Agents; Insulin; Mice; Middle Aged; Neoplasm Proteins; Nerve Tissue Proteins; Rosiglitazone; Thiazoles; Thiazolidinediones; Tumor Suppressor Proteins | 2003 |
14 other study(ies) available for rosiglitazone and glycerol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adipose Tissue, Brown; Animals; Biological Availability; Blood Glucose; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Nonesterified; Glucose; Glucose Clamp Technique; Glycerol; Heart; Hydroxybutyrates; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Liver Glycogen; Male; Muscles; Myocardium; Rats; Rats, Wistar; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides | 1994 |
BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
Topics: 3T3 Cells; Adipocytes; Animals; Carrier Proteins; Fatty Acids, Nonesterified; Glycerol; Hypoglycemic Agents; Insulin Resistance; Lipolysis; Mice; Perilipin-1; Phosphoproteins; Prostaglandin D2; Rosiglitazone; Sterol Esterase; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 1998 |
The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.
Topics: Adipocytes; Adipose Tissue; Blood Glucose; Body Composition; Calorimetry, Indirect; Diabetes Mellitus, Type 2; Fatty Acids; Glucose Clamp Technique; Glycated Hemoglobin; Glycerol; Humans; Hyperinsulinism; Insulin; Kinetics; Lipids; Lipolysis; Liver; Magnetic Resonance Spectroscopy; Microdialysis; Middle Aged; Muscle, Skeletal; Oxidation-Reduction; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides | 2002 |
Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro.
Topics: Adipocytes; Adipose Tissue; Adult; Dose-Response Relationship, Drug; Drug Synergism; Female; Glycerol; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Lipolysis; Lipoprotein Lipase; Middle Aged; Norepinephrine; Rosiglitazone; Sterol Esterase; Sympathomimetics; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2002 |
Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes.
Topics: Adipocytes; Adult; Aged; Body Mass Index; Cell Differentiation; Female; Glycerol; Humans; Hypoglycemic Agents; Leptin; Lipolysis; Male; Middle Aged; Norepinephrine; Obesity; Omentum; RNA, Messenger; Rosiglitazone; Skin; Thiazoles; Thiazolidinediones; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2002 |
Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Cells, Cultured; Cyclic AMP; Enzyme Activation; Esterification; Fatty Acids; Female; Gene Expression; Glycerol; Glycerol Kinase; Homeostasis; Hypoglycemic Agents; Isoproterenol; Lipid Metabolism; Lipolysis; Phosphoenolpyruvate Carboxykinase (GTP); Pioglitazone; Pyruvic Acid; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Viscera | 2003 |
Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin.
Topics: Animals; Blood Proteins; Fatty Acids; Fatty Acids, Nonesterified; Glycerol; Heparin; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Rats; Rosiglitazone; Thiazolidinediones; Triglycerides | 2004 |
Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro.
Topics: Adipocytes; Alitretinoin; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation; Glycerol; Isomerism; Leptin; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Tretinoin | 2004 |
Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation.
Topics: Adipose Tissue; Adult; Body Weight; Fatty Acids; Female; Glycerol; Glycerol Kinase; Humans; Hypoglycemic Agents; Phosphorylation; Pyruvates; Rosiglitazone; Thiazolidinediones | 2006 |
Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue, White; Adult; Animals; Fatty Acids; Female; Gene Expression Regulation, Enzymologic; Glycerol; Humans; Hypoglycemic Agents; Male; Mice; Middle Aged; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Rats, Sprague-Dawley; Rats, Zucker; Rosiglitazone; Subcutaneous Fat; Thiazolidinediones; Up-Regulation | 2008 |
Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.
Topics: Cell Line; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Fibroblast Growth Factors; Gene Expression Regulation; Glucose Clamp Technique; Glycerol; Homeostasis; Humans; Hyperinsulinism; Hypoglycemic Agents; Lecithins; Male; Obesity; PPAR alpha; PPAR gamma; Reference Values; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2009 |
Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study.
Topics: Antiretroviral Therapy, Highly Active; Blood Glucose; Body Composition; Calorimetry, Indirect; Fatty Acids, Nonesterified; Glycerol; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Lipid Metabolism; Lipids; Lipolysis; Male; Mass Spectrometry; Middle Aged; Palmitates; Rosiglitazone; Thiazolidinediones; Waist-Hip Ratio | 2011 |
Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.
Topics: Adiponectin; Adipose Tissue; Antiretroviral Therapy, Highly Active; Dyslipidemias; Fatty Acids, Nonesterified; Glycerol; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Lipolysis; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |